Download 13th International Conference on Cochlear Implants and Other

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Auditory system wikipedia, lookup

Audiology and hearing health professionals in developed and developing countries wikipedia, lookup

Earplug wikipedia, lookup

Olivocochlear system wikipedia, lookup

Dysprosody wikipedia, lookup

Sensorineural hearing loss wikipedia, lookup

Noise-induced hearing loss wikipedia, lookup

Hearing loss wikipedia, lookup

Speech perception wikipedia, lookup

Telecommunications relay service wikipedia, lookup

Transcript
S23-11
BoneBridge: Auditory and quality of life outcomes in conductive, mixed hearing loss and single sided
deafness
1
2
2
3
3
3
Rivas A. , Garcia L.E. , Forero V.H. , Rincon L.A. , Díaz M. , Rivas A. , Rivas J.A.
2
1
Vanderbilt University, Otolaryngology, Nashville, United States, 2Clínica Rivas, Otolaryngology, Bogota, Colombia, 3Clínica Rivas,
Audiology, Bogota, Colombia
Introduction: The transcutaneous bone conduction auditory implant Bonebridge is a new semi-implantable
device indicated for conductive and/or mixed hearing loss (C/MHL), or single sided deafness (SSD).
Objective: To evaluate the surgical outcomes, auditory benefits, quality of life and patient satisfaction scores in
conductive, mixed hearing loss and single sided deafness, in patients implanted with the Bonebridge system.
Methods: Prospective study on patients with C/MHL, or SSD. The auditory outcomes, quality of life outcomes,
and satisfaction scores with the device will be assessed.
Results: 24 patients have been implanted, including 12 males and 12 females. Fifteen of those cases were
placed in the sinodural angle and 9 in the retrosigmoid region. Twelve patients received the device for C/MHL
and 12 for SSD. C/MHL patients showed a statistical significant (p< 0.04) mean gains of 25.8 and 26 dB in PTA
at 1 and 3 months after surgery, respectively. SSD patients also showed a significant (p< 0.03) mean gains of
60.2 and 77.1 dB at 1 and 3 months after surgery, respectively. Positive indicators were obtained in general
satisfaction with the device, as well as significant improvement (p< 0.05) in the speech perception, sound
localization and quality of sound, compared to their pre-op status. Benefits in their general health and quality of
life were reported too.
Conclusions: The active transcutaneous active bone conduction auditory implant gives significant auditory gain
to patients with C/MHL and SSD. Patients report high satisfaction with the implant with improvements in their
auditory gains, general health and quality of life.
456